EBSNYSEPharmaceutical PreparationsFiscal year ends December 31

Emergent BioSolutions Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$6.36−0.02 (-0.31%)

Close on Oct 19, 2026

Market cap: $328.18M
P/E (TTM): –
Dividend yield: –

Emergent BioSolutions Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Depreciation & Amortization	24	24	24	23	24	25	26	26	29	28	30	28	33	35	36	32	45	31	29	33	33	29	-36	29	29	28	-33	28	29	27	-0.80	12	12	12	2.30	9.80	9.93	10	-0.13	10
Stock-Based Compensation	6.90	1.90	5.30	4.80	4.60	1.50	4.30	2.30	5.50	5.90	4.00	4.00	8.30	6.80	12	11	12	9.90	10	10	11	11	11	10	24	6.60	5.70	6.10	8.10	6.80	6.50	5.00	4.40	7.30	3.40	3.79	3.73	4.28	3.97	4.58
Deferred Income Taxes	2.10	-4.50	1.60	-10	-14	19	-0.40	7.30	-0.20	-12	-3.60	2.70	-1.70	-4.70	-59	23	0.70	1.90	42	3.80	-1.50	-1.70	1.00	-0.70	0.50	-4.20	4.60	-4.40	10	-11	-4.20	4.30	13	-4.50	-15	14	0.65	4.30	0.39	4.27
Other Non-Cash Items	-24	3.90	-9.10	-0.40	-2.20	11	-2.60	-4.30	-2.70	3.10	3.10	15	-9.20	-0.30	10	-11	-1.60	-0.60	3.10	-3.10	1.50	-3.50	6.20	0.50	-1.10	0	0.90	2.20	-3.00	0.10	1.30	-0.30	-1.10	-0.10	-0.50	-0.24	-0.38	-0.09	1.47	-1.69
Change in Accounts Receivable	-69	-39	52	-72	119	-73	-77	82	20	-50	37	71	-132	2.60	36	-15	4.00	94	99	-80	-77	42	-47	63	-96	108	10	-63	-97	142	-161	113	-68	22	-14	-27	26	11	-67	-8.90
Change in Inventory	24	16	14	-18	-25	-2.20	11	-18	-13	-4.50	26	-0.10	5.80	-31	46	-27	-25	-50	-8.60	22	20	-100	-19	-34	12	-26	7.70	1.70	-21	-5.20	-19	14	16	-12	0.99	1.64	0.20	3.27	7.18	3.56
Change in Accounts Payable	10	-14	11	-4.00	-10	-5.40	-10	-23	2.60	-2.40	-7.10	6.80	-20	31	-2.20	-4.20	7.10	-15	-5.10	-4.50	-12	20	18	25	1.10	-16	14	-40	38	4.20	-1.30	-1.30	-8.00	3.60	13	-1.28	4.16	0.08	-13	-13
Change in Unearned Revenue	3.30	3.20	4.10	1.20	0.20	-0.30	-1.50	0.70	0.20	-20	4.10	9.50	0.70	-8.40	5.40	1.50	4.70	-2.00	-12	400	-9.00	9.40	20	-38	29	0.50	-3.10	2.70	14	2.10	-3.00	3.10	6.60	-6.50	0.99	-3.03	7.97	9.07	5.95	-2.36
Operating Cash Flow	56	-34	78	-2.30	106	-11	-80	154	48	-63	32	60	-114	-184	93	-74	-16	-37	328	17	-30	5.10	246	105	128	58	122	-3.10	-36	105	-166	174	35	-1.00	77	35	54	42	-13	27
Capital Expenditures	-2.10	-2.40	-3.90	-3.40	-2.90	-3.60	-1.70	-5.80	-4.60	-11	-11	-13	-13	-15	-24	-28	-32	-32	-46	-55	-67	-56	-37	-46	-35	-24	-36	-15	-14	-21	-21	-26	-14	-12	-12	-13	-9.30	-20	-20	-17
Acquisitions	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–
Sale of Property, Plant & Equipment	0.20	0	0	0	0.10	38	0.30	7.60	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	–	–	0	0	–	–	0	0	–	–	–	–
Divestitures	–	–	0	–	–	–	0	110	–	–	0	0	75	–	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-52	-2.40	-3.90	-3.40	17	60	29	112	-4.60	-11	-11	-19	258	-15	-45	-272	-32	-32	-46	-55	-67	-56	-37	-46	-45	-24	-36	-15	-24	-21	-849	-26	-11	-12	-208	-13	-9.30	-20	-20	-17
Share Repurchases	-9.00	-9.00	-9.10	-8.90	-6.90	0	0	0	–	–	0	0	0	0	-0.20	0	-24	-58	-106	0	0	0	–	–	–	–	0	0	0	0	0	0	0	-0.10	-33	0	0.00	-0.08	0	0
Stock Issued	–	0.40	-1.00	–	–	0	0	0	–	–	0.20	0	–	–	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Debt Issued	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–
Taxes Paid on Share-Based Awards	-0.40	-2.80	-0.40	-0.30	-0.20	-0.50	-0.30	-0.30	-0.20	-0.40	-0.10	-0.10	-0.20	-2.10	-0.20	-0.30	-0.40	-5.00	-0.30	-0.50	-0.80	-12	-1.00	-1.10	-6.10	-5.60	-0.80	-0.30	-0.30	-6.00	-0.30	-0.30	-0.10	-5.90	-0.12	-0.13	-0.04	-4.02	3.49	-0.10
Financing Cash Flow	-24	-11	-114	-16	-6.40	-0.40	0.50	-180	-51	41	4.70	-43	-487	-11	353	229	-31	-71	-110	-5.00	-3.80	-22	-2.30	87	4.70	-20	-58	-20	100	-58	786	1.70	3.20	-2.10	-33	3.26	0.77	-23	5.21	-45
Foreign Exchange Rate Adjustments	0	0	0	-0.20	1.00	-0.70	0	0	0	0	-1.50	1.10	-0.60	-0.20	1.10	-1.00	0.70	-0.30	0	-0.20	0.20	-0.30	-0.50	-0.40	-0.20	0.10	0.50	-0.10	0	0	0.40	-0.50	-0.15	0.05	0.07	-0.06	-0.01	0.00	-0.04	-0.03
Net Change in Cash	-21	-48	-40	-22	118	47	-51	85	-8.00	-33	24	-0.80	-344	-210	402	-117	-78	-140	172	-44	-100	-74	206	146	87	14	29	-38	40	25	-228	149	27	-15	-163	25	45	-1.34	-27	-34
Free Cash Flow	54	-36	74	-5.70	104	-15	-82	148	43	-73	21	47	-127	-199	69	-102	-48	-70	282	-39	-97	-51	209	60	93	34	86	-18	-50	83	-187	148	21	-13	65	22	45	21	-33	10
Income Taxes Paid	4.30	5.30	13	11	2.10	15	-9.00	9.60	14	12	15	11	10	17	-18	3.90	15	4.80	14	7.30	49	1.50	22	75	8.60	3.60	9.60	7.80	8.40	5.00	–	–	–	–	–	–	–	–	–	–
Interest Paid	3.50	13	8.00	17	8.10	17	8.20	20	15	22	12	18	17	22	6.30	12	3.10	12	3.10	12	3.10	12	7.00	2.40	4.20	7.40	6.90	9.30	9.40	8.90	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 55.9%
Operating margin: -8.6%
Net margin: -23.0%
Return on equity, FY2025: 10.5%

Financial strength

Current ratio: 5.42
Debt to equity: 1.70
Debt to assets: 52.1%
Cash to current liabilities: 113.8%

Valuation

P/E ratio: –
Price to sales: 0.43
Price to book: 0.96
Dividend yield: –